Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CSL627_3001

Abstract

A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII-SingleChain, CSL627) in Subjects with Severe Hemophilia A

Keywords

• CSL627
• Hemophilia A